| Pain Mechanisms and Treatments | Lifetime | 16 | DE 2 | 99.87 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 14 | DE 2 | 99.84 |
| Hereditary Neurological Disorders | Lifetime | 6 | DE 2 | 99.60 |
| Peripheral Neuropathies and Disorders | Lifetime | 17 | DE 2 | 99.75 |
| Pharmacological Effects of Natural Compounds | Lifetime | 35 | DE 3 | 99.47 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 30 | DE 5 | 99.46 |
| Musculoskeletal pain and rehabilitation | Lifetime | 130 | DE 6 | 99.49 |
| Nerve injury and regeneration | Lifetime | 81 | DE 5 | 99.33 |
| Pain Management and Treatment | Lifetime | 44 | DE 8 | 98.67 |
| Neuropeptides and Animal Physiology | Lifetime | 322 | DE 17 | 98.75 |
| Myofascial pain diagnosis and treatment | Lifetime | 94 | DE 8 | 97.99 |
| Pain Management and Placebo Effect | Lifetime | 112 | DE 11 | 98.15 |
| Lysosomal Storage Disorders Research | Lifetime | 190 | DE 17 | 97.68 |
| Peripheral Nerve Disorders | Lifetime | 162 | DE 6 | 97.58 |
| Healthcare and Venom Research | Lifetime | 244 | DE 10 | 96.61 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 103 | DE 19 | 96.74 |
| Myasthenia Gravis and Thymoma | Lifetime | 281 | DE 22 | 96.39 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 274 | DE 18 | 95.50 |
| Pain Management and Opioid Use | Lifetime | 492 | DE 23 | 95.56 |
| Pain Mechanisms and Treatments | 2021-2025 | 9 | DE 2 | 99.29 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 30 | DE 4 | 98.20 |
| Musculoskeletal pain and rehabilitation | 2021-2025 | 147 | DE 6 | 97.86 |
| Hereditary Neurological Disorders | 2021-2025 | 18 | DE 1 | 96.49 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 65 | DE 4 | 96.06 |
| Pain Management and Treatment | 2021-2025 | 71 | DE 2 | 93.88 |
| Pain Management and Placebo Effect | 2021-2025 | 69 | DE 12 | 92.41 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 231 | DE 37 | 93.56 |
| Lysosomal Storage Disorders Research | 2021-2025 | 572 | DE 56 | 79.80 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 731 | DE 47 | 79.70 |
| Autoimmune Neurological Disorders and Treatments | 2021-2025 | 420 | DE 61 | 74.59 |
| Pain Management and Opioid Use | 2021-2025 | 693 | DE 20 | 74.05 |
| Myasthenia Gravis and Thymoma | 2021-2025 | 766 | DE 56 | 68.85 |
| Myofascial pain diagnosis and treatment | 2021-2025 | 900 | DE 32 | 60.63 |
| Dermatological and Skeletal Disorders | 2021-2025 | 458 | DE 43 | 57.32 |
